Endpoints News ٣ مارس ٢٠٢٦ After years of dispute with FDA, Vanda will get a public hearing for jet lag drug
Endpoints News ٣ مارس ٢٠٢٦ FDA explains how some copycat drugs can still win three years of exclusivity
Endpoints News ٣ مارس ٢٠٢٦ EveryOne Medicines shuts down, ending custom cure venture that banked on new FDA pathway
Endpoints News ٣ مارس ٢٠٢٦ Boehringer Ingelheim tried to use a tempting, tough cancer target for liver disease. It didn’t work
Endpoints News ٣ مارس ٢٠٢٦ Hims partner Strive Pharmacy will reintroduce GLP-1 pill pulled from market
Endpoints News ٢ مارس ٢٠٢٦ United Therapeutics to take pulmonary hypertension drug to FDA for approval
Endpoints News ٢ مارس ٢٠٢٦ Aardvark's stock plummets on study pause; BioNTech heads to Phase 3 with DualityBio ADC
Endpoints News ٢ مارس ٢٠٢٦ Roche gets third pivotal win with MS drug, but liver signal could be a problem